Clinical Trial Update: Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease

View source ↗

Summary

A clinical trials update on the natural history, pathogenesis, and outcomes of Melorheostosis (a rare osteosclerotic bone disease), currently recruiting under N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melorheostosis

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Rheumatic Disease | Status: RECRUITING